The American Rescue Plan stimulus package includes $10 billion to be distributed to support COVID-19 testing in schools, plus another $2.5 billion to help state and local public health agencies increase testing in underserved and high-risk communities. And that's not all: Another $4 billion will be routed to the Indian Health Service's Tribal and Urban Indian health programs to fight COVID-19 in Native American communities, and some of that, too, will go toward increasing testing.
Market leaders Illumina (NASDAQ: ILMN) , Fulgent Genetics (NASDAQ: FLGT) , and 10x Genomics (NASDAQ: TXG) all appear ready to take healthy slices of the newly bolstered market for COVID-19 diagnostics.
Image source: Getty Images
For further details see:
3 Healthcare Stocks About to be Bolstered by Biden's American Rescue Plan